Bicycle Therapeutics PLC (NASDAQ:BCYC)
| 20.55 Delayed Data As of Mar 24 |  +0.20 / +0.98%Today’s Change | 12.08 Today|||52-Week Range 50.47 | -30.57% Year-to-Date |
Latest BCYC News | Press Releases
No recent news for Bicycle Therapeutics PLC.
Today’s Trading
| Previous close | 20.35 |
| Today’s open | 20.15 |
| Day’s range | 19.95 - 20.84 |
| Volume | 8,309 |
| Average volume (3 months) | 285,476 |
| Market cap | $620.2M |
Data as of 3:59pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | -42.46% |
| Earnings growth (this year) | -20.65% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +23.59% |
| P/E ratio | NM |
| Price/Sales | 60.74 |
| Price/Book | 2.28 |
Competitors
| ---- | ||
| RAPTRapt Therapeutics In... | -0.58 | -3.22% |
| ANABAnaptysBio Inc | -0.19 | -0.88% |
| ANIPANI Pharmaceuticals ... | -0.46 | -1.22% |
Data as of 4:00pm ET, 03/24/2023
Financials
| Next reporting date | May 4, 2023 |
| EPS forecast (this quarter) | -$1.08 |
| Annual revenue (last year) | $14.5M |
| Annual profit (last year) | -$112.6M |
| Net profit margin | -779.35% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Cambridgeshire |
Forecasts
